| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer
|
Rao, Krishna
|
|
2013
|
72 |
3 |
p. 545-552
|
artikel
|
| 2 |
A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
|
Rathkopf, Dana E.
|
|
2013
|
72 |
3 |
p. 537-544
|
artikel
|
| 3 |
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients
|
Bemer, Meagan J.
|
|
2013
|
72 |
3 |
p. 607-618
|
artikel
|
| 4 |
A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
|
Chao, Yee
|
|
2013
|
72 |
3 |
p. 637-642
|
artikel
|
| 5 |
Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel
|
Sémiond, D.
|
|
2013
|
72 |
3 |
p. 515-528
|
artikel
|
| 6 |
Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study
|
Yoo, Changhoon
|
|
2013
|
72 |
3 |
p. 565-575
|
artikel
|
| 7 |
Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival
|
Cardoso-Filho, Cassio
|
|
2013
|
72 |
3 |
p. 529-535
|
artikel
|
| 8 |
Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
|
Iwamoto, Marian
|
|
2013
|
72 |
3 |
p. 493-508
|
artikel
|
| 9 |
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids
|
Sun, Susan
|
|
2013
|
72 |
3 |
p. 509-513
|
artikel
|
| 10 |
CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702)
|
Mochizuki, Yoshinari
|
|
2013
|
72 |
3 |
p. 629-635
|
artikel
|
| 11 |
Effects of β-lapachone, a new anticancer candidate, on cytochrome P450-mediated drug metabolism
|
Kim, In Sook
|
|
2013
|
72 |
3 |
p. 699-702
|
artikel
|
| 12 |
Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing
|
Podolski-Renić, Ana
|
|
2013
|
72 |
3 |
p. 683-697
|
artikel
|
| 13 |
Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells
|
Hamed, Salaheldin S.
|
|
2013
|
72 |
3 |
p. 553-563
|
artikel
|
| 14 |
Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors
|
Honda, Kazunori
|
|
2013
|
72 |
3 |
p. 577-584
|
artikel
|
| 15 |
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours
|
Seto, Takashi
|
|
2013
|
72 |
3 |
p. 619-627
|
artikel
|
| 16 |
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer
|
Song, Taejong
|
|
2013
|
72 |
3 |
p. 653-660
|
artikel
|
| 17 |
Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese patients with advanced colorectal cancer
|
Doi, Toshihiko
|
|
2013
|
72 |
3 |
p. 643-652
|
artikel
|
| 18 |
Scheduling of paclitaxel and gefitinib to inhibit repopulation for optimal treatment of human cancer cells and xenografts that overexpress the epidermal growth factor receptor
|
Fung, Andrea S.
|
|
2013
|
72 |
3 |
p. 585-595
|
artikel
|
| 19 |
Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia
|
Goldschmidt, Neta
|
|
2013
|
72 |
3 |
p. 709-713
|
artikel
|
| 20 |
The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer
|
Mohelnikova-Duchonova, Beatrice
|
|
2013
|
72 |
3 |
p. 669-682
|
artikel
|
| 21 |
The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor
|
Visentin, Michele
|
|
2013
|
72 |
3 |
p. 597-606
|
artikel
|
| 22 |
The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin
|
Shaw, Jiajiu
|
|
2013
|
72 |
3 |
p. 703-707
|
artikel
|
| 23 |
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes
|
Kolesar, Jill M.
|
|
2013
|
72 |
3 |
p. 661-667
|
artikel
|
Tijdschrift beschrijving